Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03001180 · ClinicalTrials.gov registry record
Identification of Biomarkers for Patients with Vascular Anomalies
A clinical trial of Klippel-Trenaunay Syndrome and Kaposiform Lymphangiomatosis, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT03001180 is a study of Klippel-Trenaunay Syndrome and Kaposiform Lymphangiomatosis that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 1,000 participants, above the 436-participant average among 3 other Klippel-Trenaunay Syndrome trials with a reported enrollment target (129% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT03001180, a study of Klippel-Trenaunay Syndrome and Kaposiform Lymphangiomatosis, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.
Conditions Studied
Study Locations (2)
Massachusetts
- Boston Children's Hospital - Boston
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2015-04 |
| Est. Completion | 2050-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03001180
The ClinicalTrials.gov registry entry for NCT03001180 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 436-participant average among 3 other Klippel-Trenaunay Syndrome trials with a reported enrollment target (129% higher). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Klippel-Trenaunay Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT03001180 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Ohio.
Frequently Asked Questions
What is clinical trial NCT03001180 about?
NCT03001180 is a clinical study titled "Identification of Biomarkers for Patients with Vascular Anomalies". The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Dep...
What is the current status of trial NCT03001180?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2015-04. Estimated completion is 2050-12.
What conditions does trial NCT03001180 study?
This clinical trial studies the following conditions: Klippel-Trenaunay Syndrome, Kaposiform Lymphangiomatosis, Vascular Anomaly, Generalized Lymphatic Anomaly, Kaposiform Hemangioendothelioma.
Who is sponsoring clinical trial NCT03001180?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03001180 being conducted?
This trial has 2 study locations across Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Klippel-Trenaunay Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphatic Anomalies Registry for the Assessment of Outcome Data
RECRUITING
-
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
RECRUITING · Phase 2
-
Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Klippel-Trenaunay Syndrome
All registered trials for this condition
Kaposiform Lymphangiomatosis
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.